vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与RESOURCES CONNECTION, INC.（RGP）财务数据对比。点击上方公司名可切换其他公司
RESOURCES CONNECTION, INC.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.6倍（$117.7M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -19.2%），RESOURCES CONNECTION, INC.自由现金流更多（$15.6M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -11.8%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
RGP原名 Resources Global Professionals，是 Resources Connection, Inc. 的核心运营主体，面向全球客户提供多领域专业咨询服务，覆盖财务会计、信息管理、治理风险合规、人力资本、法务监管、企业咨询与重组、战略传播以及供应链管理等板块。
PBYI vs RGP — 直观对比
营收规模更大
RGP
是对方的1.6倍
$75.5M
营收增速更快
PBYI
高出46.9%
-19.2%
自由现金流更多
RGP
多$1.2M
$14.4M
两年增速更快
PBYI
近两年复合增速
-11.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $117.7M |
| 净利润 | — | $-12.7M |
| 毛利率 | 69.3% | 37.1% |
| 营业利润率 | 22.7% | -10.3% |
| 净利率 | — | -10.8% |
| 营收同比 | 27.7% | -19.2% |
| 净利润同比 | — | 81.6% |
| 每股收益（稀释后） | $0.26 | $-0.38 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIRGP
| Q4 25 | $75.5M | $117.7M | ||
| Q3 25 | $54.5M | $120.2M | ||
| Q2 25 | $52.4M | $139.3M | ||
| Q1 25 | $46.0M | $129.4M | ||
| Q4 24 | $59.1M | $145.6M | ||
| Q3 24 | $80.5M | $136.9M | ||
| Q2 24 | $47.1M | $148.2M | ||
| Q1 24 | $43.8M | $151.3M |
净利润PBYIRGP
| Q4 25 | — | $-12.7M | ||
| Q3 25 | $8.8M | $-2.4M | ||
| Q2 25 | $5.9M | $-73.3M | ||
| Q1 25 | $3.0M | $-44.1M | ||
| Q4 24 | — | $-68.7M | ||
| Q3 24 | $20.3M | $-5.7M | ||
| Q2 24 | $-4.5M | $10.5M | ||
| Q1 24 | $-4.8M | $2.5M |
毛利率PBYIRGP
| Q4 25 | 69.3% | 37.1% | ||
| Q3 25 | 77.7% | 39.5% | ||
| Q2 25 | 76.5% | 40.2% | ||
| Q1 25 | 77.1% | 35.1% | ||
| Q4 24 | 76.4% | 38.5% | ||
| Q3 24 | 63.9% | 36.5% | ||
| Q2 24 | 77.4% | 40.2% | ||
| Q1 24 | 75.5% | 37.0% |
营业利润率PBYIRGP
| Q4 25 | 22.7% | -10.3% | ||
| Q3 25 | 17.6% | -1.7% | ||
| Q2 25 | 12.7% | -47.0% | ||
| Q1 25 | 8.7% | -38.4% | ||
| Q4 24 | 22.6% | -52.7% | ||
| Q3 24 | 27.4% | -3.5% | ||
| Q2 24 | -4.6% | 7.6% | ||
| Q1 24 | -5.3% | 2.8% |
净利率PBYIRGP
| Q4 25 | — | -10.8% | ||
| Q3 25 | 16.2% | -2.0% | ||
| Q2 25 | 11.2% | -52.6% | ||
| Q1 25 | 6.5% | -34.0% | ||
| Q4 24 | — | -47.2% | ||
| Q3 24 | 25.2% | -4.2% | ||
| Q2 24 | -9.6% | 7.1% | ||
| Q1 24 | -11.0% | 1.7% |
每股收益（稀释后）PBYIRGP
| Q4 25 | $0.26 | $-0.38 | ||
| Q3 25 | $0.17 | $-0.07 | ||
| Q2 25 | $0.12 | $-2.21 | ||
| Q1 25 | $0.06 | $-1.34 | ||
| Q4 24 | $0.40 | $-2.08 | ||
| Q3 24 | $0.41 | $-0.17 | ||
| Q2 24 | $-0.09 | $0.31 | ||
| Q1 24 | $-0.10 | $0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $89.8M |
| 总债务越低越好 | $22.7M | — |
| 股东权益账面价值 | $130.3M | $194.6M |
| 总资产 | $216.3M | $289.3M |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
现金及短期投资PBYIRGP
| Q4 25 | $97.5M | $89.8M | ||
| Q3 25 | $94.4M | $77.5M | ||
| Q2 25 | $96.0M | $86.1M | ||
| Q1 25 | $93.2M | $72.5M | ||
| Q4 24 | $101.0M | $78.2M | ||
| Q3 24 | $96.7M | $89.6M | ||
| Q2 24 | $96.8M | $108.9M | ||
| Q1 24 | $107.2M | $113.8M |
总债务PBYIRGP
| Q4 25 | $22.7M | — | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYIRGP
| Q4 25 | $130.3M | $194.6M | ||
| Q3 25 | $115.3M | $206.4M | ||
| Q2 25 | $104.7M | $207.1M | ||
| Q1 25 | $97.1M | $277.8M | ||
| Q4 24 | $92.1M | $325.7M | ||
| Q3 24 | $71.1M | $407.2M | ||
| Q2 24 | $48.5M | $418.8M | ||
| Q1 24 | $51.0M | $414.9M |
总资产PBYIRGP
| Q4 25 | $216.3M | $289.3M | ||
| Q3 25 | $202.9M | $287.2M | ||
| Q2 25 | $194.9M | $304.7M | ||
| Q1 25 | $196.2M | $375.6M | ||
| Q4 24 | $213.3M | $424.9M | ||
| Q3 24 | $220.7M | $512.9M | ||
| Q2 24 | $205.0M | $510.9M | ||
| Q1 24 | $214.1M | $523.2M |
负债/权益比PBYIRGP
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $15.9M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $15.6M |
| 自由现金流率自由现金流/营收 | 19.1% | 13.2% |
| 资本支出强度资本支出/营收 | 0.0% | 0.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | $24.3M |
8季度趋势，按日历期对齐
经营现金流PBYIRGP
| Q4 25 | $14.4M | $15.9M | ||
| Q3 25 | $9.7M | $-7.8M | ||
| Q2 25 | $14.1M | $16.8M | ||
| Q1 25 | $3.6M | $659.0K | ||
| Q4 24 | $15.6M | $1.8M | ||
| Q3 24 | $11.0M | $-309.0K | ||
| Q2 24 | $1.0M | $3.2M | ||
| Q1 24 | $11.2M | $20.5M |
自由现金流PBYIRGP
| Q4 25 | $14.4M | $15.6M | ||
| Q3 25 | $9.7M | $-8.0M | ||
| Q2 25 | $14.1M | $16.5M | ||
| Q1 25 | $3.6M | $238.0K | ||
| Q4 24 | $15.6M | $61.0K | ||
| Q3 24 | $11.0M | $-575.0K | ||
| Q2 24 | $1.0M | $3.0M | ||
| Q1 24 | — | $20.4M |
自由现金流率PBYIRGP
| Q4 25 | 19.1% | 13.2% | ||
| Q3 25 | 17.7% | -6.6% | ||
| Q2 25 | 26.8% | 11.8% | ||
| Q1 25 | 7.7% | 0.2% | ||
| Q4 24 | 26.4% | 0.0% | ||
| Q3 24 | 13.7% | -0.4% | ||
| Q2 24 | 2.1% | 2.1% | ||
| Q1 24 | — | 13.5% |
资本支出强度PBYIRGP
| Q4 25 | 0.0% | 0.3% | ||
| Q3 25 | 0.0% | 0.1% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.1% | 0.3% | ||
| Q4 24 | 0.0% | 1.2% | ||
| Q3 24 | 0.0% | 0.2% | ||
| Q2 24 | 0.0% | 0.1% | ||
| Q1 24 | 0.0% | 0.1% |
现金转化率PBYIRGP
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | 0.30× | ||
| Q1 24 | — | 8.04× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PBYI
暂无分部数据
RGP
| US | $93.7M | 80% |
| Non Us | $24.0M | 20% |
